$52.68
1.372.67%
Últ. Act.: Oct 22, 4:34 PM
$52.68
1.372.67%
Pulse Biosciences (PLSE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.29 | $-0.24 | $-0.25 | $-0.31 |
| Actual | $-0.36 | $-0.27 | $-0.26 | $-0.29 |
| Surprise | -24.1% | -12.5% | -4.00% | +6.45% |
| Revenue | ||||
| Estimate | $566664 | $420000 | $250000 | $500000 |
| Actual | $434000 | $401000 | $264000 | $86000 |
| Surprise | -23.4% | -4.52% | +5.60% | -82.8% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.30 | $-0.31 | $-0.35 | $-0.35 |
| Revenue | ||||
| Consensus | $517336 | $706000 | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.36 | $-0.29 | -24.1 % |
| Q1 | May 4, 2026 | $-0.27 | $-0.24 | -12.5 % |
| Q4 | Feb 19, 2026 | $-0.26 | $-0.25 | -4.00 % |
| Q3 | Nov 5, 2025 | $-0.29 | $-0.31 | 6.45 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $434.00K | $566.66K | -23.4 % |
| Q1 | May 4, 2026 | $401.00K | $420.00K | -4.52 % |
| Q4 | Feb 19, 2026 | $264.00K | $250.00K | 5.60 % |
| Q3 | Nov 5, 2025 | $86.00K | $500.00K | -82.8 % |